openPR Logo
Press release

Implantable Drug Delivery Market Trends 2020 to 2025 || Leading Players - Theragenics, Psivida, Kinamed Inc., K2M Inc., Mako Surgical Corp., Varian Medical System, Arrow International

01-16-2020 12:21 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Implantable Drug Delivery Market

Implantable Drug Delivery Market

The Global Implantable Drug Delivery Market is expected to reach USD 36.12 billion by 2025, from USD 19.36 billion in 2017 growing at a CAGR of 8.0% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Have Queries? To request a sample or speak to an expert click here https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-implantable-drug-delivery-market&raksh

Some of the major players operating in the global implantable drug delivery market are Bayer, Boston Scientific, Medtronic, Merck&Co. Inc., Allergan Inc., Bausch and Lomb, Inc., ithetis, Nucletron,Genetech Inc., Theragenics, Psivida, Kinamed Inc., K2M Inc., Mako Surgical Corp., Varian Medical System, Arrow International, Eckert Ziegler, Elekta, JVS, and Abbottamong among others.

The Implantable Drug Delivery market report contains information and data in the form of charts, tables and graphs which is easily understandable to the users. This report deals with several markets internationally including Asia, North America, South America, and Africa in accord with the client’s needs. It endows them with the best possible solutions and meticulous information about the market trends.

The best analytical methods have been employed in the report, namely SWOT analysis and Porter’s Five Forces analysis wherever applicable. What is more, the report offers advanced information and scenario about the Healthcare industry which helps to stand apart in the competition in this fast paced business environment. This Implantable Drug Delivery market report also offers insights into revenue generation and sustainability initiative.

To get this report at an attractive cost, click here https://www.databridgemarketresearch.com/speak-to-analyst?dbmr=global-implantable-drug-delivery-market&raksh

Market Definition: Global Implantable Drug Delivery Market

Implantable drug delivery devices are medical devices that allow site specific drug management. It also offers the minimization of the doses of drug for the reduction of potential side effects. The implantable devices are reaching more attention as compared to the conservative oral and parenteral dosage forms because of the site specific and sustained release therapeutic action, implantable devices that again minimizes the side-effects associated with the drug.

The most prominent cause of blindness in people is implantable drug delivery between the ages of 20-64 in the United States. According to a study by National Eye Institute (NEI), almost 5.4 million people in the U.S. will suffer from Age related Macular Degeneration (AMD) by 2050. Due to this the number of surgeries increasing and will cause the implantable drug delivery devices market to grow.

Market Segmentation: Global Implantable Drug Delivery Market

The global implantable drug delivery market is segmented based on Product Type, Technology, Application, and Geography

By product types the global implantable drug delivery market is segmented into implantable bio-absorbable stents, implantable contraceptive drug delivery devices, implantable intraocular drug delivery devices, implantable coronary drug eluting stents, implantable brachytherapy seeds and implantable drug infusion pumps.

By technology the global implantable drug delivery market is segmented into biodegradable implantable drug delivery device technology and non-biodegradable implantable drug delivery device technology.

Key Developments in the Implantable Drug Delivery Market:

In March 2016, FDA approved V-Go, a wearable 24 hour subcutaneous insulin delivery device by Medtronic for diabetes management, which have helped diabetes treatment outcome.

In April 2013, Bayer Healthcare launched a hormonal intrauterine device (IUD) called Skyla. The product is launched in Europe with the brand name Jaydess, and is used for the prevention of pregnancy for up to three years.

Table of Content: Global Implantable Drug Delivery Market

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Global Implantable Drug Delivery Market Landscape

Part 04: Global Implantable Drug Delivery Market Sizing

Part 05: Global Implantable Drug Delivery Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Continue…. For Detailed TOC of Implantable Drug Delivery Market Report, Click Here https://www.databridgemarketresearch.com/toc?dbmr=global-implantable-drug-delivery-market&raksh

Scope of the Implantable Drug Delivery Market Report : -

The report shields the development activities in the Implantable Drug Delivery Market which includes the status of marketing channels available, and an analysis of the regional export and import. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments. This will benefit the report’s users, that evaluates their position in Implantable Drug Delivery market as well as create effective strategies in the near future. 

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Implantable Drug Delivery Market Trends 2020 to 2025 || Leading Players - Theragenics, Psivida, Kinamed Inc., K2M Inc., Mako Surgical Corp., Varian Medical System, Arrow International here

News-ID: 1898027 • Views: 214

More Releases from Data Bridge Market Research

Global Immune Checkpoint Inhibitors Market Analysis, Market Size, Market Growth, …
To prosper in this competitive market place, businesses consider taking up innovative solutions and market research report is one of them. Analysis and estimations derived through the enormous information gathered in this Global Immune Checkpoint Inhibitors Market analysis report are extremely necessary when it comes to dominating the market or creating a mark in the market as a new emergent. A lot of efforts have been put together and no
Global Urothelial Cancer Drugs Market Recent Trends, In-depth Analysis, Market S …
Global Urothelial Cancer Drugs Market report studies and analyses facts and figures about the market segmentation very carefully and represent it in the form of graphs for the better understanding of end user. It not only identifies the emerging trends along with major drivers, challenges and opportunities in the market but also analyses them efficiently. The market report has been specially designed by keeping in mind the customer requirements with
Global Drug Discovery Informatics Market At A CAGR Of 11.27% Growth, Trends And …
Global Drug Discovery Informatics Market is expected to rise from its initial estimated value of USD 1.85 billion in 2018 to an estimated value of USD 4.34 billion by 2026, registering a CAGR of 11.27% in the forecast period of 2019-2026. Increasing investment on R&D is driving the growth of this market. The Drug Discovery Informatics market report evaluates CAGR value fluctuation during the forecast period of 2019 -2026 for
Global ELISA Tests Market Forecasts 2019 To 2026: By Ortho Clinical Diagnostics, …
Global ELISA tests market is expected to rise from to an estimated value of USD 2529.97 million by 2026 registering a substantial CAGR in the forecast period of 2019-2026. This rise in the market can be attributed to rising prevalence of cancer, rising ageing population and technological advancements. This ELISA tests report provides key statistics on the market status of Global and Regional manufacturers and is a valuable source of

All 5 Releases


More Releases for Implantable

Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025. For In depth Information Get
Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantabl …
The Global Active Implantable Medical Devices Market by product type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 16,721.2 million in 2016 and is projected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), as highlighted in a new
Implantable Ports Market - Competition Framework 2017-2025
Global Implantable Ports Market: Overview Implantable ports, which are long, narrow, soft, and thin plastic tubes with a rubber disc at the end, are frequently inserted into chemotherapy patients in order to administrate drugs to individuals. Also called as portacaths or subcutaneous, the diameter of implantable ports ranges from 2.5 cm to 4 cm and are highly useful for patients receiving treatment into a vein. Blood transfusions, chemotherapy, intravenous (IV) fluids,
Implantable Ports Market Sharp Rise over 2025
Global Implantable Ports Market: Overview Implantable ports, which are long, narrow, soft, and thin plastic tubes with a rubber disc at the end, are frequently inserted into chemotherapy patients in order to administrate drugs to individuals. Also called as portacaths or subcutaneous, the diameter of implantable ports ranges from 2.5 cm to 4 cm and are highly useful for patients receiving treatment into a vein. Blood transfusions, chemotherapy, intravenous (IV) fluids,
Implantable Medical Devices Market: A comprehensive survey
The global market for implantable medical devices market is experiencing an increased demand due to rampant technological advancements. The market is highly consolidated as the top four players account for a little over 50% of the market share making it difficult for new players to enter the market. Moreover, the research excellence attained by these established players overpowers the ability of other small and medium sized players to innovate and
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of